Table 2.
Penetrance, Female Gametophyte Specificity, and Phenotype
| Mutant | Penetrance in FGa | Penetrance in MGa | Terminal Phenotypeb |
|---|---|---|---|
| ctr1-2 | 58%c | 0%c | Wild type (5) |
| fem2 | 44%d | 0%d | Stage FG1d (1) |
| fem3 | 42%d | 44%d | Stage FG1d (1) |
| fem4 | 100%d | 42%d | Abnormal cellular morphology, stage FG5/6/7 (3) |
| fem5 | 87% (685) | 72% (1799) | Abnormal nuclear number, size, and position (2) |
| fem6 | 93% (455) | 86% (811) | Abnormal cellular morphology (3) |
| fem7 | 81% (831) | 30% (614) | Abnormal cellular morphology (3) |
| fem8 | 67% (441) | 9%e (623) | Abnormal cellular morphology (3) |
| fem9 | 42% (431) | 12%e (857) | Stage FG1 (1) |
| fem10 | 93% (1275) | 92% (1347) | Abnormal nuclear number and position (2) |
| fem11 | 54% (624) | 100% (100) | Stage FG1 to stage FG6 (2) |
| fem12 | 73% (1111) | 100% (403) | Stage FG1 (1) |
| fem13 | 84% (406) | 100% (423) | Abnormal nuclear number, cellularization; twinning (2) |
| fem14 | 79% (105) | 100% (218) | Abnormal nuclear number, position; collapse (2) |
| fem15 | 100% (99) | 64% (64) | Abnormal nuclear number and cellularization (2) |
| fem16 | 66% (206) | 71% (298) | No FG (1) |
| fem17 | 98% (66) | 10%e (133) | Wild type (5) |
| fem18 | 39% (305) | 65% (694) | Stage FG1 to stage FG2 (1) |
| fem19 | 100% (306) | 100% (459) | Abnormal nuclear number and position (2) |
| fem20 | 34% (154) | 0% (413) | Stage FG1, stage FG5 (2) |
| fem21 | 100% (108) | 100% (376) | Stage FG3 to stage FG5 (2) |
| fem22 | 100% (710) | 99% (601) | Stage FG4 to stage FG5 (2) |
| fem23 | 98% (826) | 43% (1024) | Stage FG3 to stage FG5 (2) |
| fem24 | 83% (504) | 16% (726) | Stage FG1, stage FG3 to stage FG5 (2) |
| fem25 | 86% (342) | 99% (847) | Abnormal nuclear number, position; stage FG1 to FG2 (2) |
| fem26 | 99% (260) | 17% (796) | Stage FG1 (1) |
| fem29 | 17% (387) | 71% (535) | Stage FG1 (1) |
| fem30 | 15% (183) | 97% (774) | Stage FG1 to stage FG5; abnormal nuclear number (2) |
| fem31 | 66% (506) | 88% (256) | Stage FG1, stage FG3 (1) |
| fem33 | 94% (174) | 70% (214) | Stage FG1, stage FG3 to stage FG4 (2) |
| fem34 | 100% (300) | 98% (360) | Stage FG3 (2) |
| fem35 | 35% (295) | 31% (602) | Stage FG1 (1) |
| fem36 | 99% (315) | 92% (246) | Stage FG1, stage FG3 to stage FG4 (2) |
| fem37 | 42% (328) | 16% (668) | Stage FG1 (1) |
| fem38 | 51% (330) | 53% (355) | Stage FG1 (1) |
| gfa2 | 99% (571) | 86% (704) | Unfused polar nucleid (4) |
| gfa3 | 82% (281) | 99% (365) | Unfused polar nuclei, cellularization failured (4) |
| gfa4 | 61% (1252) | 100% (908) | Stage FG1d (1) |
| gfa5 | 79% (441) | 84% (649) | Stage FG1d (1) |
a
FG, female gametophyte; MG, male gametophyte. The number of progeny scored is in parentheses.
b
Phenotypic category is in parentheses.
c
Previously described by Kieber and Ecker (1994).
d
Previously described by Christensen et al. (1998).
e
Not significantly different from 0 at P < 0.05.